NCT06269588View on ClinicalTrials.gov

Efficacy and Safety of Nexpowder™ for Non-variceal, Upper Gastrointestinal Bleeding

NARecruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 29, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Gastrointestinal HemorrhageHematemesis; With UlcerEndoscopy
Interventions
DEVICE

Nexpowder

Endoscopic hemostasis

Trial Locations (1)

529889

RECRUITING

Changi General Hospital, Singapore

All Listed Sponsors
collaborator

Next Biomedical Co., Ltd.

INDUSTRY

collaborator

Tan Tock Seng Hospital

OTHER

collaborator

National University Hospital, Singapore

OTHER

lead

Changi General Hospital

OTHER